Longeveron Share Price (NASDAQ: LGVN)

$0.81

▲

0.05

(6.58%)

Live

Last updated on August 18, 2025 at 11:46 PM IST

$₹

Check the interactive Longeveron Stock chart to analyse performance

Longeveron stock performance

as on August 18, 2025 at 11:46 PM IST

Today's Low:$0.73
Today's High:$0.81
$0.81
9.33%
Downside
Day's Volatility :9.33%
Upside
0.0%
52 Weeks Low:$0.63
52 Weeks High:$2.86
$0.81
21.85%
Downside
52 Weeks Volatility :77.87%
Upside
71.68%

Longeveron Stock Returns

Period	Longeveron Inc	Index (Russel 2000)
3 Months	-45.71%	0.0%
6 Months	-51.9%	0.0%
1 Year	-67.8%	0.0%
3 Years	-98.56%	-11.6%

Longeveron Inc Key Stats

Check Longeveron key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$0.76
Open	$0.78
Today's High	$0.81
Today's Low	$0.7344
Market Capitalization	$11.5M
Today's Volume	$676.2K
52 Week High	$2.86
52 Week Low	$0.633
Revenue TTM	$2.1M
EBITDA	$-18.3M
Earnings Per Share (EPS)	$0.25
PE Ratio	3.02
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-134.52%

Stock Returns calculator for Longeveron Stock including INR - Dollar returns

The Longeveron stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Longeveron investment value today

Current value as on today

₹38,396

Returns

₹61,604

(-61.6%)

Returns from Longeveron Stock

₹65,678 (-65.68%)

Dollar Returns*

₹4,073 (+4.07%)

Indian investors sentiment towards Longeveron Stock

90%

Period: Jul 18, 2025 to Aug 17, 2025. Change in 30 Days versus previous period

Search interest for Longeveron Stock from India on INDmoney has increased by 90% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Longeveron Inc

Name
Holdings %
Name
Holdings %
Vanguard Group Inc
0.96%
Geode Capital Management, LLC
0.94%
UBS Group AG
0.37%
State Street Corp
0.30%
Capital Investment Advisory Services, LLC
0.18%
Commonwealth Equity Services Inc
0.11%

Analyst Recommendation on Longeveron Stock

Rating

Trend

Buy

87%Buy

12%Hold

0%Sell

Based on 8 Wall street analysts offering stock ratings for Longeveron(by analysts ranked 0 to 5 stars)

Longeveron Share Price Target

What analysts predicted

Upside of 935.49%

Target:

$8.39

Current:

$0.81

Longeveron share price target is $8.39, a slight Upside of 935.49% compared to current price of $0.81 as per analysts' prediction.

Longeveron Stock Insights

Price Movement
In the last 1 month, LGVN stock has moved down by -50.0%
Decreasing Revenue
Revenue is down for the last 4 quarters, 773.0K → 316.0K (in $), with an average decrease of 25.3% per quarter
Decreasing Net Profit
Netprofit is down for the last 3 quarters, -4.08M → -5.02M (in $), with an average decrease of 11.6% per quarter
LGVN vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 67.4% return, outperforming this stock by 135.1%
LGVN vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 100.9% return, outperforming this stock by 199.5%
Price to Sales
ForLGVN every $1 of sales, investors are willing to pay $5.3, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.6 for every $1 of sales.

Longeveron Inc Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$5.6M	↑ 164.17%
Net Income	$-3.0M	↓ 52.73%
Net Profit Margin	-53.12%	↑ 243.72%

	FY20	Y/Y Change
Revenue	$5.6M	↓ 0.18%
Net Income	$-3.8M	↑ 26.56%
Net Profit Margin	-67.35%	↓ 14.23%

	FY21	Y/Y Change
Revenue	$1.3M	↓ 76.8%
Net Income	$-17.2M	↑ 352.73%
Net Profit Margin	-1.3K%	↓ 1246.89%

	FY22	Y/Y Change
Revenue	$1.2M	↓ 6.43%
Net Income	$-19.6M	↑ 14.35%
Net Profit Margin	-1.6K%	↓ 291.9%

	FY23	Y/Y Change
Revenue	$709.0K	↓ 41.98%
Net Income	$-21.4M	↑ 9.1%
Net Profit Margin	-3.0K%	↓ 1414.03%

	FY24	Y/Y Change
Revenue	$2.4M	↑ 237.38%
Net Income	$-16.0M	↓ 25.41%
Net Profit Margin	-667.77%	↑ 2352.4%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$548.0K	↑ 769.84%
Net Income	$-4.1M	↓ 32.68%
Net Profit Margin	-740.51%	↑ 8827.74%

	Q2 FY24	Q/Q Change
Revenue	$468.0K	↓ 14.6%
Net Income	$-3.4M	↓ 15.89%
Net Profit Margin	-729.27%	↑ 11.24%

	Q3 FY24	Q/Q Change
Revenue	$773.0K	↑ 65.17%
Net Income	$-4.4M	↑ 29.48%
Net Profit Margin	-571.67%	↑ 157.6%

	Q4 FY24	Q/Q Change
Revenue	$603.0K	↓ 21.99%
Net Income	$-4.1M	↓ 7.65%
Net Profit Margin	-676.78%	↓ 105.11%

	Q1 FY25	Q/Q Change
Revenue	$381.0K	↓ 36.82%
Net Income	$-5.0M	↑ 22.79%
Net Profit Margin	-1.3K%	↓ 638.44%

	Q2 FY25	Q/Q Change
Revenue	$316.0K	↓ 17.06%
Net Income	$-5.0M	↑ 0.34%
Net Profit Margin	-1.6K%	↓ 275.92%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$1.8M	↑ 157.71%

	FY20	Y/Y Change
Profit	$1.8M	↑ 4.12%

	FY21	Y/Y Change
Profit	$590.0K	↓ 67.69%

	FY22	Y/Y Change
Profit	$497.0K	↓ 15.76%

	FY23	Y/Y Change
Profit	$221.0K	↓ 55.53%

	FY24	Y/Y Change
Profit	$1.9M	↑ 752.49%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$76.0K	↓ 131.93%

	Q2 FY24	Q/Q Change
Profit	$344.0K	↑ 352.63%

	Q3 FY24	Q/Q Change
Profit	$682.0K	↑ 98.26%

	Q4 FY24	Q/Q Change
Profit	$530.0K	↓ 22.29%

	Q1 FY25	Q/Q Change
Profit	$275.0K	↓ 48.11%

	Q2 FY25	Q/Q Change
Profit	$146.0K	↓ 46.91%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$-2.4M	↓ 53.83%
Investing Cash Flow	$-125.0K	↓ 40.93%
Financing Cash Flow	$350.0K	↓ 74.17%

	FY20	Y/Y Change
Operating Cash Flow	$-2.4M	↓ 1.13%
Investing Cash Flow	$-261.5K	↑ 109.12%
Financing Cash Flow	$1.6M	↑ 350.09%

	FY21	Y/Y Change
Operating Cash Flow	$-9.6M	↑ 307.63%
Investing Cash Flow	$-10.7M	↑ 3990.25%
Financing Cash Flow	$45.2M	↑ 2767.59%

	FY22	Y/Y Change
Operating Cash Flow	$-14.0M	↑ 44.97%
Investing Cash Flow	$-677.0K	↓ 93.67%
Financing Cash Flow	$-509.0K	↓ 101.13%

	FY23	Y/Y Change
Operating Cash Flow	$-19.0M	↑ 36.03%
Investing Cash Flow	$8.2M	↓ 1309.16%
Financing Cash Flow	$5.3M	↓ 1133.79%

	FY24	Y/Y Change
Operating Cash Flow	$-13.9M	↓ 27.02%
Investing Cash Flow	$-640.0K	↓ 107.82%
Financing Cash Flow	$28.8M	↑ 447.15%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-3.1M	↓ 22.79%
Investing Cash Flow	$14.0K	↓ 99.1%
Financing Cash Flow	$63.0K	↓ 98.84%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$-4.6M	↑ 47.96%
Investing Cash Flow	$-53.0K	↓ 478.57%
Financing Cash Flow	$15.1M	↑ 23795.24%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$-2.8M	↓ 37.74%
Investing Cash Flow	$-478.0K	↑ 801.89%
Financing Cash Flow	$13.7M	↓ 8.83%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$-3.4M	↑ 18.64%
Investing Cash Flow	$-123.0K	↓ 74.27%
Financing Cash Flow	$-50.0K	↓ 100.36%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$-4.7M	↑ 39.25%
Investing Cash Flow	$-150.0K	↑ 21.95%
Financing Cash Flow	$-58.0K	↑ 16.0%

Longeveron Technicals Summary

Sell

Neutral

Buy

Longeveron is currently in a neutral trading position according to technical analysis indicators.

Longeveron Inc Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Longeveron Inc	-54.76%	-51.9%	-67.8%	-98.56%	-98.97%
Regeneron Pharmaceuticals, Inc.	6.39%	-14.65%	-51.51%	-6.14%	-7.82%
Beone Medicines Ltd	10.08%	34.96%	66.94%	83.8%	36.85%
Vertex Pharmaceuticals Incorporated	-14.33%	-15.0%	-19.52%	31.35%	45.44%
Alnylam Pharmaceuticals, Inc.	40.06%	79.56%	63.55%	107.86%	227.15%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Longeveron Inc	3.02	3.02	NA	0.0	-1.35	-0.67	NA	0.84
Regeneron Pharmaceuticals, Inc.	14.62	14.62	1.19	39.42	0.15	0.07	0.0	287.55
Beone Medicines Ltd	NA	NA	NA	2.33	-0.05	-0.01	NA	34.32
Vertex Pharmaceuticals Incorporated	27.94	27.94	0.58	18.04	0.23	0.13	NA	67.02
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	3.92	-2.58	-0.03	NA	1.91

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Longeveron Inc	Buy	$11.5M	-98.97%	3.02	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$61.5B	-7.82%	14.62	31.37%
Beone Medicines Ltd	NA	$38.8B	36.85%	NA	-3.89%
Vertex Pharmaceuticals Incorporated	Buy	$100.7B	45.44%	27.94	31.86%
Alnylam Pharmaceuticals, Inc.	Buy	$58.0B	227.15%	NA	-12.96%

About Longeveron Inc

Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States. Its lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and healthy adult donors which is in phase 1 clinical trial to treat hypoplastic left heart syndrome; completed phase 2a clinical trial to treat Alzheimer's disease, as well as in phase 2b clinical trial to treat aging frailty. The company was incorporated in 2014 and is headquartered in Miami, Florida.

Organization	Longeveron
Employees	25
CEO	Mr. Mohamed Wa'el Ahmed Hashad M.B.A.
Industry	Miscellaneous

Key Management of Longeveron Inc

Name	Title
Dr. Joshua Michael Hare FACC, M.D.	Co-Founder, Chief Science Officer & Chairman
Mr. Mohamed Wa'el Ahmed Hashad M.B.A.	CEO & Director
Ms. Lisa A. Locklear M.B.A.	CFO, Executive VP & Treasurer
Mr. Paul T. Lehr J.D.	General Counsel & Secretary
Mr. Devin Blass	CTO & Senior VP of Chemistry, Manufacturing, and Controls
Ms. Jen Dumas	Vice President of Human Resources
Ms. Lisa McClain-Moss	Vice President of Manufacturing
Mr. Brian G Rash Ph.D.	VP of Research & Discovery
Mr. Than Powell	VP & Chief Business Officer
Ms. Heather Zhou	VP & Corporate Controller

Important FAQs about investing in LGVN Stock from India :

What is Longeveron share price today?

Longeveron share price today is $0.81 as on August 18, 2025 at 11:46 PM IST. Longeveron share today touched a day high of $0.81 and a low of $0.73.

What is the 52 week high and 52 week low for Longeveron share?

Longeveron share touched a 52 week high of $2.86 and a 52 week low of $0.63. Longeveron stock price today, August 18, 2025 at 11:46 PM IST is trending at $0.81, lower by 71.68% versus the 52 week high.

How to invest in Longeveron Stock (LGVN) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Longeveron on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Longeveron Shares that will get you 1.8519 shares as per Longeveron share price of $0.81 per share as on August 18, 2025 at 11:46 PM IST.

What is the minimum amount required to buy Longeveron Stock (LGVN) from India?

Indian investors can start investing in Longeveron (LGVN) shares with as little as ₹87.3775 or $1 (as of August 18, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹873.77 in Longeveron stock (as per the Rupee-Dollar exchange rate as on August 18, 2025). Based on Longeveron share’s latest price of $0.81 as on August 18, 2025 at 11:46 PM IST, you will get 12.3457 shares of Longeveron. Learn more about fractional shares .

What are the returns that Longeveron has given to Indian investors in the last 5 years?

Longeveron stock has given -98.97% share price returns and 16.91% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?